Joseph Shilati

Regulation of MLL/COMPASS stability through its proteolytic cleavage by taspase1 as a possible approach for clinical therapy of leukemia

A. Shilatifard, Lu Wang, Zibo Zhao, 2018, Genes & development.

ERK1/2 phosphorylation predicts survival following anti-PD-1 immunotherapy in recurrent glioblastoma

D. Brat, R. Stupp, R. Rabadán, 2021, Nature Cancer.